FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034450678> ?p ?o ?g. }

• W2034450678 endingPage "49" @default.
• W2034450678 startingPage "46" @default.
• W2034450678 abstract "Background and objective: The variations of blood coagulation and anticoagulation are of clinical importance in patients with acute cerebral infarction during intravenous urokinase (UK) thrombolysis. Although intravenous heparin is commonly used after thrombolytic therapy, few reports have addressed the relationship between the degree of anticoagulation and clinical outcomes, specifically the effect of thrombolytic agents on hemostasis. In this study, we dynamically monitored the activated partial thromboplastin time (APTT), the prothrombin time (PT), the thrombin time (TT) and the activated partial thromboplasmin time (APTT) in 56 patients with acute cerebral infarction during intravenous urokinase thrombolysis and analysed the relationship among the blood coagulation biomarkers (APTT, PT, TT, AT-III), as well as baseline patient characteristics and clinical outcomes. This allowed us to explore the valuable biomarkers for securing the thrombolysis regimen in clinical practice. Methods: The levels of PT, APTT, TT and AT-III in peripheral blood of 56 patients with acute cerebral infarction and 50 normal controls were assayed by ELISA. Dynamic transformation of these markers at the baseline and the time points of the first, second, fourth, eighth, 12th, 24th, 48th, 72nd and 96th hour after intravenous UK thrombolysis was monitored serially. The relationship between the levels of these biomarkers and the clinical effectiveness and safety of urokinase thrombolysis was evaluated. Results: The levels of PT, APTT, TT and AT-III in patients before intravenous UK thrombolysis were significantly lower than those in age- and sex-matched normal controls (all p<0.05). After treatment with UK, the levels of PT and APTT rose quickly during the first 4 hours (all p< 0.05), and then gradually recovered, reaching baseline at about the 48th hour. The activity of AT-III was slightly increased and showed fluctuations after UK infusion (p< 0.05), however the fluctuated range was not remarkable and lacked specificity. Conclusions: Dynamic monitoring of PT, APTT and TT can indicate coagulative and anticoagulative functions of patients with acute cerebral infarction during intravenous urokinase thrombolysis. Monitoring of these markers can be helpful both in regulating the infusion speed and the dosage of UK, as well as increasing the efficacy and safety of UK therapy. However, assay for AT-III might be unnecessary." @default.
• W2034450678 created "2016-06-24" @default.
• W2034450678 creator A5001821199 @default.
• W2034450678 creator A5002413621 @default.
• W2034450678 creator A5041731322 @default.
• W2034450678 creator A5065898323 @default.
• W2034450678 creator A5081844561 @default.
• W2034450678 date "2006-01-01" @default.
• W2034450678 modified "2023-09-26" @default.
• W2034450678 title "Dynamic change of coagulation and anticoagulation markers of patients with acute cerebral infarction during intravenous urokinase thrombolysis" @default.
• W2034450678 cites W1977091674 @default.
• W2034450678 cites W1981618267 @default.
• W2034450678 cites W2012213508 @default.
• W2034450678 cites W2042310162 @default.
• W2034450678 cites W2049691341 @default.
• W2034450678 cites W2054458521 @default.
• W2034450678 cites W2060616517 @default.
• W2034450678 cites W2070645997 @default.
• W2034450678 cites W2079726914 @default.
• W2034450678 cites W2080594979 @default.
• W2034450678 cites W2086766648 @default.
• W2034450678 cites W2087397283 @default.
• W2034450678 cites W2092308883 @default.
• W2034450678 cites W2108828773 @default.
• W2034450678 cites W2115990895 @default.
• W2034450678 cites W2130289969 @default.
• W2034450678 cites W2160243792 @default.
• W2034450678 cites W2467537272 @default.
• W2034450678 cites W335575960 @default.
• W2034450678 doi "https://doi.org/10.1179/016164106x91861" @default.
• W2034450678 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16464362" @default.
• W2034450678 hasPublicationYear "2006" @default.
• W2034450678 type Work @default.
• W2034450678 sameAs 2034450678 @default.
• W2034450678 citedByCount "8" @default.
• W2034450678 countsByYear W20344506782017 @default.
• W2034450678 countsByYear W20344506782018 @default.
• W2034450678 countsByYear W20344506782020 @default.
• W2034450678 countsByYear W20344506782021 @default.
• W2034450678 crossrefType "journal-article" @default.
• W2034450678 hasAuthorship W2034450678A5001821199 @default.
• W2034450678 hasAuthorship W2034450678A5002413621 @default.
• W2034450678 hasAuthorship W2034450678A5041731322 @default.
• W2034450678 hasAuthorship W2034450678A5065898323 @default.
• W2034450678 hasAuthorship W2034450678A5081844561 @default.
• W2034450678 hasConcept C126322002 @default.
• W2034450678 hasConcept C164705383 @default.
• W2034450678 hasConcept C2776892390 @default.
• W2034450678 hasConcept C2777557582 @default.
• W2034450678 hasConcept C2778261982 @default.
• W2034450678 hasConcept C2778382381 @default.
• W2034450678 hasConcept C2779036427 @default.
• W2034450678 hasConcept C2779581417 @default.
• W2034450678 hasConcept C2780077467 @default.
• W2034450678 hasConcept C2780434524 @default.
• W2034450678 hasConcept C42219234 @default.
• W2034450678 hasConcept C500558357 @default.
• W2034450678 hasConcept C71924100 @default.
• W2034450678 hasConceptScore W2034450678C126322002 @default.
• W2034450678 hasConceptScore W2034450678C164705383 @default.
• W2034450678 hasConceptScore W2034450678C2776892390 @default.
• W2034450678 hasConceptScore W2034450678C2777557582 @default.
• W2034450678 hasConceptScore W2034450678C2778261982 @default.
• W2034450678 hasConceptScore W2034450678C2778382381 @default.
• W2034450678 hasConceptScore W2034450678C2779036427 @default.
• W2034450678 hasConceptScore W2034450678C2779581417 @default.
• W2034450678 hasConceptScore W2034450678C2780077467 @default.
• W2034450678 hasConceptScore W2034450678C2780434524 @default.
• W2034450678 hasConceptScore W2034450678C42219234 @default.
• W2034450678 hasConceptScore W2034450678C500558357 @default.
• W2034450678 hasConceptScore W2034450678C71924100 @default.
• W2034450678 hasIssue "1" @default.
• W2034450678 hasLocation W20344506781 @default.
• W2034450678 hasLocation W20344506782 @default.
• W2034450678 hasOpenAccess W2034450678 @default.
• W2034450678 hasPrimaryLocation W20344506781 @default.
• W2034450678 hasRelatedWork W1975287477 @default.
• W2034450678 hasRelatedWork W2156546608 @default.
• W2034450678 hasRelatedWork W2317139092 @default.
• W2034450678 hasRelatedWork W2351323014 @default.
• W2034450678 hasRelatedWork W2358177439 @default.
• W2034450678 hasRelatedWork W2364718100 @default.
• W2034450678 hasRelatedWork W2364809393 @default.
• W2034450678 hasRelatedWork W2375972067 @default.
• W2034450678 hasRelatedWork W2389270980 @default.
• W2034450678 hasRelatedWork W4285367771 @default.
• W2034450678 hasVolume "28" @default.
• W2034450678 isParatext "false" @default.
• W2034450678 isRetracted "false" @default.
• W2034450678 magId "2034450678" @default.
• W2034450678 workType "article" @default.